CorMedix

$8.04
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.17 (2.16%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell CorMedix and other stocks, options, ETFs, and crypto commission-free!

About CRMD

CorMedix, Inc. operates as a pharmaceutical and medical device company, which seeks to in-license, develop and commercialize prophylactic and therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The firm is developing its product Neutrolin, a novel, non-antibiotic antimicrobial solution designed to prevent costly and dangerous bloodstream infections associated with the use of central venous catheters. Read More The company was founded by Antony E. Pfaffle in 2006 and is headquartered in Berkeley Heights, NJ.

Employees
22
Headquarters
Berkeley Heights, New Jersey
Founded
2006
Market Cap
191.55M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
151.54K
High Today
$8.08
Low Today
$7.82
Open Price
$7.98
Volume
89.82K
52 Week High
$13.70
52 Week Low
$2.65

Collections

CRMD Earnings

-$0.28
-$0.18
-$0.08
$0.02
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
Actual
Expected Nov 14, After Hours

Popular Stocks

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.